Your browser doesn't support javascript.
loading
Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma.
Adi, Sabag D; Eiza, Nasren; Bejar, Jacob; Shefer, Hila; Toledano, Shira; Kessler, Ofra; Neufeld, Gera; Toubi, Elias; Vadasz, Zahava.
Afiliación
  • Adi SD; Proteomic Unit, The Division of Clinical Immunology and Allergy, Bnai-Zion Medical Center, Haifa, Israel.
  • Eiza N; Proteomic Unit, The Division of Clinical Immunology and Allergy, Bnai-Zion Medical Center, Haifa, Israel.
  • Bejar J; The Department of Pathology, Faculty of Medicine, Bnai-Zion Medical Center, Haifa, Israel.
  • Shefer H; The Department of Pathology, Faculty of Medicine, Bnai-Zion Medical Center, Haifa, Israel.
  • Toledano S; The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
  • Kessler O; The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
  • Neufeld G; The Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
  • Toubi E; Proteomic Unit, The Division of Clinical Immunology and Allergy, Bnai-Zion Medical Center, Haifa, Israel.
  • Vadasz Z; Proteomic Unit, The Division of Clinical Immunology and Allergy, Bnai-Zion Medical Center, Haifa, Israel.
Front Immunol ; 10: 550, 2019.
Article en En | MEDLINE | ID: mdl-30967873
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Linfocitos T Reguladores / Neovascularización Fisiológica / Semaforina-3A Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Front Immunol Año: 2019 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Asma / Linfocitos T Reguladores / Neovascularización Fisiológica / Semaforina-3A Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Front Immunol Año: 2019 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Suiza